Print

Edison Expands European Biotech Presence with Initiation of Research Coverage on TRANSGENE (TRGNY)  
1/17/2012 9:16:46 AM

LONDON--(BUSINESS WIRE)--Edison Investment Research, a UK-based independent equity research firm, announces the initiation of research coverage on Transgene (NYSE Euronext Paris: TNG), a French immunotherapy drug discovery and development company.
//-->